Concr launches trial using digital twins for outcome prediction in breast cancer
London, United Kingdom, 10 July 2024 – Concr announces that first patients have been recruited to the VISION trial, an observational clinical study evaluating Concr’s therapeutic response predictive algorithm defining biomarkers of chemotherapy and immunotherapy response in early Triple Negative Breast Cancer (TNBC).
